欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
Lisofylline (raceimic)_6493-06-7_产品详情
6493-06-7
  • Lisofylline (raceimic)

  • names:

    1-[5-Hydroxyhexyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione

  • CAS号:

    6493-06-7

    MDL Number:
  • MF(分子式): C13H20N4O3 MW(分子量): 280.33
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:BIOFOUNT
Lisofylline (raceimic)
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名 Lisofylline (raceimic)
英文别名 LSF; Lisofylline; Lisofylline; CT 1501R; ProTec;
CAS号 6493-06-7
Inchi InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3
InchiKey NSMXQKNUPPXBRG-UHFFFAOYSA-N
分子式 Formula C13H20N4O3
分子量 Molecular Weight 280.33
溶解度Solubility
性状 Solid powder
储藏条件 Storage conditions Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).
产品说明 Lisofylline (raceimic)(CAS:6493-06-7):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。
IntroductionLisofylline, also known as LSF, improves cellular mitochondrial function and blocks interleukin-12 (IL-12) signaling and STAT-4 activation in target cells and tissues. IL-12 and STAT-4 activation are important pathways linked to inflammation and autoimmune damage to insulin producing cells. Therefore, LSF and related analogs could provide a new therapeutic approach to prevent or reverse type 1 diabetes.
Application1
Application2
Application3
警示图
危险性 Warning
危险性警示
安全声明
安全防护
备注
[1]Jung HS, Kaplan LJ, Park PK. Reviewing the studies of the National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome Network: outcomes and clinical findings. Curr Probl Surg. 2013 Oct;50(10):451-62. doi: 10.1067/j.cpsurg.2013.08.009. Review. PubMed PMID: 24156843.
[2]Jain R, DalNogare A. Pharmacological therapy for acute respiratory distress syndrome. Mayo Clin Proc. 2006 Feb;81(2):205-12. Review. PubMed PMID: 16471076.
[3] Yang Z, Chen M, Nadler JL. Lisofylline: a potential lead for the treatment of diabetes. Biochem Pharmacol. 2005 Jan 1;69(1):1-5. Review. PubMed PMID: 15588708.
[4] Wiedemann HP, Arroliga AC, Komara JJ Jr. Emerging systemic pharmacologic approaches in acute respiratory distress syndrome. Respir Care Clin N Am. 2003 Dec;9(4):419-35. Review. PubMed PMID: 14984064.
[5] Bhandari V. Developmental differences in the role of interleukins in hyperoxic lung injury in animal models. Front Biosci. 2002 Jul 1;7:d1624-33. Epub 2002 Jul 1. Review. PubMed PMID: 12108429.
6: Sturm A, Dignass AU. Modulation of gastrointestinal wound repair and inflammation by phospholipids. Biochim Biophys Acta. 2002 May 23;1582(1-3):282-8. Review. PubMed PMID: 12069839.7: Bright JJ, Sriram S. Immunotherapy of inflammatory demyelinating diseases of the central nervous system. Immunol Res. 2001;23(2-3):245-52. Review. PubMed PMID: 11444389.8: Nemunaitis J. Recombinant hematopoietic growth factors in bone marrow transplantation. Cancer Treat Res. 1995;7
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents